Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2Qing Zhou, Troy R. Torgerson, John S. Barber et al.|New England Journal of Medicine|2014Cited by 889
Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutationsLisa R. Forbes, Jennifer W. Leiding, Tiphanie P. Vogel et al.|Journal of Allergy and Clinical Immunology|2018Cited by 261
Clinical, Immunological, and Molecular Heterogeneity of 173 Patients With the Phenotype of Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked (IPEX) SyndromeEleonora Gambineri, Troy R. Torgerson, Sara Ciullini Mannurita et al.|Frontiers in Immunology|2018Cited by 186
Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contactsWilliam T. Shearer, Jerry A. Winkelstein, Thomas A. Fleisher et al.|Journal of Allergy and Clinical Immunology|2014Cited by 150
The Extended Clinical Phenotype of 26 Patients with Chronic Mucocutaneous Candidiasis due to Gain-of-Function Mutations in STAT1Mark Depner, Bodo Grimbacher, Sebastian Fuchs et al.|Journal of Clinical Immunology|2015Cited by 137